Shehan Makani

  The Formulation Gap | PrintChem by ChemeNova ChemeNova Intelligence Report | Vol. 01 · April 2026 · Open Access Formulation Intelligence The Formulation Gap Nobody Talks About How PrintChem closes a $4.2B blind spot in the global printing ink industry — and why the answer was never going to come from ChatGPT. S Shehan Makani Founder, ChemeNova LLC · NJIT Tech MBA Ink Chemistry AI Formulation PrintChem Open Source $27 B Global Ink Market 2025 8.1 % CAGR — Digital Inks 30 s PrintChem Formulation Time 1197 Validated Ink Ingredients The Market Problem Ink Is Not Just Color. And That Is Precisely Why Formulators Keep Failing. In the global printing ink industry — valu...

Chemenova LLC · Product Update We Built an AI Formulation Co-Pilot for the Specialty Chemicals Industry. Try It Free. IntelliForm is a prototype — honest, open-source, and already doing things that used to take months of lab time. We want your feedback. SM Shehan Makani, Founder & CEO · Chemenova LLC · March 2025 · 5 min read The specialty chemicals industry is a $600B+ market that still reformulates largely by intuition, tribal knowledge, and expensive iteration cycles. A mid-size formulator might spend 6–18 months cycling through candidate formulations for a single product line — testing, failing, adjusting, repeating. We think that timeline is a solvable engineering problem. Not with better lab equipment. With better intelligence. What We Built IntelliForm is Chemenova's AI-powered formulation intelligence platform. The prototype — available today, free, no login required — lets you: → Run multi-objective optimization across up to 18 chemical properties simultaneously using ...

Beyond Predictive Modeling: The Rise of Agentic Chemical OS | Shehan Makani ChemeNova Research Journal  ·  AI × Sustainable Chemistry  ·  March 2026 Perspectives on Deep Technology Beyond Predictive Modeling: The Rise of the Agentic Chemical OS How Multi-Objective Bayesian Optimization and Agentic AI are rewriting the rules of sustainable chemical commerce — and why the next frontier is execution, not just prediction. Shehan Makani Founder & CEO, ChemeNova March 9, 2026 12 min read For decades, chemical R&D has operated on a "Trial and Error tax" — spending 70% of the innovation cycle in a Valley of Despair between molecular design and commercially viable product. Even with the arrival of AI, most tools remain passive observers. At ChemeNova, we are building something categorically different: an Agentic Operating System for Chemistry that not on...